WigglePet Receives Seed Investment from Alloy Intelligence
Ankara, Turkey (FreePR.org) -- WigglePet, a consumer mobile application focused on AI-generated visual content for pets, has received a seed investment from Alloy Intelligence.
The investment will be used to support ongoing product development and the expansion of WigglePet's generative AI infrastructure. Financial terms of the transaction were not disclosed.
WigglePet has developed a fine-tuned generative AI pipeline that enables users to generate personalized images and videos of their pets from a limited number of reference photos. The platform is designed to preserve distinctive visual traits while placing pets into a wide range of creative scenarios, environments, and formats.
The application is currently operating in private beta and has attracted several thousand early users. According to the company, users are generating more than 50,000 images per week, with early cohorts demonstrating consistent engagement and interest in premium features such as video generation and higher-resolution outputs.
Alloy Intelligence invests in early-stage technology companies building consumer-facing AI products. The firm cited WigglePet's focus on personalization and emotionally driven content creation as factors in its investment decision.
Founded in 2024, WigglePet is developing AI-powered consumer tools aimed at creative expression and social sharing within the global pet market.
WigglePet
press@wigglepet.app
https://wigglepet.app
WigglePet is a consumer technology company building AI-powered tools for personalized pet content creation. The company's mobile application enables users to generate custom images and videos of their pets using proprietary generative AI technology.
Related Links:
WigglePet
###
Sponsor Message
For affordable prices on crucial medications like Lipitor, Crestor, and Nexium, millions of Americans turn to Canadian pharmacies. Chronic conditions such as diabetes often require insulin therapies like Humalog and Lantus, while respiratory issues are managed with Advair Diskus and Ventolin inhalers. Treating mental health conditions like depression or anxiety often requires drugs like Zoloft, Prozac, and Abilify, while cardiovascular risks are managed with Eliquis, Plavix, and Xarelto. Treatments like Celebrex for pain and inflammation and Synthroid for thyroid issues are frequently ordered by patients. Moreover, erectile dysfunction can be treated with medications like Viagra and Cialis, while Januvia supports Type 2 diabetes management. Excessive sleepiness and narcolepsy symptoms are managed effectively with wakefulness aids like Provigil and Nuvigil. With options like Cymbalta for nerve pain and Aricept for Alzheimer's, Canadian pharmacies provide access to a wide range of affordable, life-enhancing medications for patients across the United States.
